fluorodeoxyglucose f18 has been researched along with Basedow Disease in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 2 (14.29) | 24.3611 |
| 2020's | 4 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Califaretti, E; Dall'armellina, S; Deandreis, D; Finessi, M; Rovera, G | 1 |
| Goh, HJ; Ho, WE; Leow, MKS; Sun, L; Tint, MT | 1 |
| Chudek, J; Nalewajka-Kołodziejczak, J; Ochmann, A; Winder, M | 1 |
| Abdul Shakoor, SAKK; Chan, SP; Chew, CK; Chew, DE; Dalan, R; Goh, HJ; Govindharajulu, P; Henry, CJ; Hoi, WH; Jadegoud, Y; Lee, Y; Leow, MKS; Liew, H; Lim, BSP; Michael, N; Quek, TPL; Sadananthan, SA; Sun, L; Velan, SS; Verma, S; Yeo, PS | 1 |
| Asa, S; Cicik, E; Kabasakal, L; Sağer, S; Sönmezoğlu, K; Uslu-Beşli, L | 1 |
| Guan, Y; Hua, F; Li, Y; Miao, Q; Ye, H; Zhang, Q; Zhang, Z; Zuo, C | 1 |
| Chen, YK; Chen, YL | 1 |
| Chen, YK; Chen, YL; Kao, CH; Liao, AC; Shen, YY | 1 |
| Bartenstein, P; Buchholz, HG; Drecker, S; Egle, UT; Kahaly, GJ; Schreckenberger, MF; Weber, MM | 1 |
| Chen, YK; Chen, YL; Cheng, RH; Hsu, CH; Lee, CC; Yeh, CL | 1 |
| Chen, YK; Chiu, JS; Wang, YF | 1 |
| Boerner, AR; Schicha, H; Theissen, P; Voth, E; Wagner, R; Wienhard, K | 1 |
| Börner, AR; Schicha, H; Voth, E; Wagner, R; Wienhard, K | 1 |
| Abdel-Dayem, HM; El-Zeftawy, H; Jana, S; Naddaf, S; Santiago, JF | 1 |
1 review(s) available for fluorodeoxyglucose f18 and Basedow Disease
| Article | Year |
|---|---|
Current imaging methods for assessing Graves` orbitopathy activity with particular emphasis on FDG-PET.
Topics: Fluorodeoxyglucose F18; Graves Disease; Graves Ophthalmopathy; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
4 trial(s) available for fluorodeoxyglucose f18 and Basedow Disease
| Article | Year |
|---|---|
Metabolic effects of brown fat in transitioning from hyperthyroidism to euthyroidism.
Topics: Adipose Tissue, Brown; Adult; Aged; Antithyroid Agents; Body Composition; Carbimazole; Energy Metabolism; Female; Fluorodeoxyglucose F18; Graves Disease; Humans; Hyperthyroidism; Magnetic Resonance Imaging; Male; Methimazole; Middle Aged; Positron-Emission Tomography; Remission Induction; Singapore; Thermogenesis; Thyroid Gland; Young Adult | 2021 |
Orbital flourine-18-fluorodeoxyglucose positron emission tomography in patients with Graves' disease for evaluation of active inflammation.
Topics: Adult; Case-Control Studies; Female; Fluorodeoxyglucose F18; Graves Disease; Humans; Inflammation; Iodine Radioisotopes; Male; Orbit; Positron Emission Tomography Computed Tomography | 2017 |
Elevated 18F-FDG uptake in skeletal muscles and thymus: a clue for the diagnosis of Graves' disease.
Topics: Adult; Aged; Blood Glucose; Female; Fluorodeoxyglucose F18; Graves Disease; Humans; Male; Middle Aged; Muscle, Skeletal; Radiopharmaceuticals; Thymus Gland; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Positron emission tomography reveals correlations between brain metabolism and mood changes in hyperthyroidism.
Topics: Adult; Aged; Brain; Brain Mapping; Case-Control Studies; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Glucose; Graves Disease; Humans; Male; Middle Aged; Mood Disorders; Pilot Projects; Positron-Emission Tomography; Thyroid Hormones | 2006 |
9 other study(ies) available for fluorodeoxyglucose f18 and Basedow Disease
| Article | Year |
|---|---|
The role of PET/CT in thyroid autoimmune diseases.
Topics: Autoimmune Diseases; COVID-19; Fluorodeoxyglucose F18; Graves Disease; Humans; Male; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; SARS-CoV-2 | 2022 |
Brown adipose tissue influences adiponectin and thyroid hormone changes during Graves' disease therapy.
Topics: Adiponectin; Adipose Tissue; Adipose Tissue, Brown; Fluorodeoxyglucose F18; Graves Disease; Humans; Hyperthyroidism; Thyroid Hormones | 2022 |
The effects of thyroid hormones on brown adipose tissue in humans: a PET-CT study.
Topics: Adipose Tissue, Brown; Adiposity; Adult; Antithyroid Agents; Energy Metabolism; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Graves Disease; Humans; Male; Methimazole; Middle Aged; Muscle, Skeletal; Positron-Emission Tomography; Thyroid Hormones; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2014 |
Elevated F-18 FDG uptake in the thymus in Graves' disease.
Topics: Adult; Female; Fluorodeoxyglucose F18; Graves Disease; Humans; Radiopharmaceuticals; Thymus Hyperplasia; Tomography, Emission-Computed | 2003 |
The significance of FDG uptake in bilateral thyroid glands.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Graves Disease; Humans; Hyperthyroidism; Male; Middle Aged; Muscle, Skeletal; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Gland; Thyroid Neoplasms; Ultrasonography | 2007 |
Diagnostic trinity: Graves' disease on F-18 FDG PET.
Topics: Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Graves Disease; Humans; Male; Muscle, Skeletal; Positron-Emission Tomography; Radiopharmaceuticals; Thymus Gland; Thyroid Gland | 2007 |
Glucose metabolism of the thyroid in Graves' disease measured by F-18-fluoro-deoxyglucose positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Blood Volume; Female; Fluorodeoxyglucose F18; Glucose; Graves Disease; Humans; Iodine Radioisotopes; Male; Middle Aged; Thyroid Gland; Tomography, Emission-Computed | 1998 |
[F-qi-FDG PET of the thyroid gland in Graves' disease].
Topics: Adult; Aged; Autoantibodies; Biological Transport; Female; Fluorodeoxyglucose F18; Graves Disease; Half-Life; Humans; Iodine Radioisotopes; Male; Middle Aged; Radiopharmaceuticals; Reference Values; Regression Analysis; Thyroid Gland; Tissue Distribution; Tomography, Emission-Computed | 1998 |
Increased F-18 fluorodeoxyglucose thyroidal uptake in Graves' disease.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Graves Disease; Humans; Iodine Radioisotopes; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Function Tests | 1999 |